Indeed, ShcA cooperates with Neu/ErbB2 signaling in the control of cell motility and invasion in transformed epithelial cells [77], through effects on focal adhesion turnover [5,77], and increased p52/46ShcA levels enhance migration of prostate carcinoma cells [60]. The gene discussed is SHC1; the disease is prostate carcinoma.